Syncardia Systems
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Arizona, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1992 E Silverlake Rd, Tucson, Arizona, 8...Phone Number
(520) 545-1234Website
www.syncardia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Syncardia Systems
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.Explore more
Syncardia Systems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Syncardia Systems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Syncardia Systems had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Syncardia Systems has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Syncardia Systems launches new products
Check out if Syncardia Systems is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Syncardia Systems
Check if Syncardia Systems has recently received funding, and reach out quickly before it becomes old news!
Syncardia Systems, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Syncardia Systems recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Syncardia Systems
Compare insights from companies similar to Syncardia Systems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Syncardia Systems is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Syncardia Systems is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Syncardia Systems.
Syncardia Systems financials insights
Gather financial insights about Syncardia Systems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Series B
$3.7M
2009
Series D
$10.3M
2011
Private Equity
$5M
2013
Debt
$14M
2014
Private Equity
$6.4M
2020
Debt
$1M
2021
Debt
$1.9M
Syncardia Systems Tech Stack
A closer look at the technologies used by Syncardia Systems
See more technologies
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Syncardia Systems has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
Syncardia Systems News & Media
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —Picard Medical (NYSE: PMI) posts growth but faces going-concern and listing test
Picard Medical reports revenue growth, improving margins and debt reduction, while disclosing a going-concern qualification and NYSE American equity deficiency notice that requires a compliance plan by June 7, 2026.PICARD MEDICAL, INC. Issues Letter to Shareholders
TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of the world’s first and only total artificial heart approved by both the U.S. FDA and Health Canada, today issued the following letter to shareholders:Picard Medical / SynCardia Reports First Quarter 2026 Financial Results
– Gross profit turns positive; Company executes significant debt reduction –
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Syncardia Systems
Sign Up For FreeTo access detailed company insights
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transp... Read More
